Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT06100952

Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Conditions: Keratoconus

Sex: All

Ages: 8 Years – 45 Years

Healthy volunteers: No

Phase: PHASE3

Enrollment: 398

Sponsor: Epion Therapeutics

Location: Schwartz Laser Eye Center Scottsdale Arizona

Summary

A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Eligibility Criteria

Inclusion Criteria: * Diagnosis of keratoconus Exclusion Criteria: * Minimal corneal thickness \< 350 microns * Non-keratoconic ectatic disease * Contraindications or hypersensitivities to any required study medications * Pregnancy or breastfeeding * Certain concomitant ocular conditions

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06100952). StuddyBuddy aggregates publicly available trial information.